Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 2:46 PM ET

Pharmaceuticals

Company Overview of Aerial BioPharma LLC

Company Overview

Aerial BioPharma LLC, a biopharmaceutical company, engages in drug development for central nervous system. The company focuses on developing biologics and small molecules for conditions that are affected by processes in the central nervous system. Aerial BioPharma LLC was founded in 2011 and is based in Morrisville, North Carolina.

9001 Aerial Center Parkway

Aerial Center Executive Park

Suite 110

Morrisville, NC 27703

United States

Founded in 2011

Phone:

919-460-9500

Fax:

919-460-9509

Key Executives for Aerial BioPharma LLC

Co-Founder and Chief Executive Officer
Co-Founder, President and Chief Operating Officer
Co-Founder and Executive Vice President of Drug Development
Acting Chief Financial Officer
Senior Director of Chemistry and Manufacturing
Compensation as of Fiscal Year 2015.

Aerial BioPharma LLC Key Developments

Jazz Pharmaceuticals Announces Acquisition from Aerial BioPharma LLC of Rights to Late Stage Investigational Compound for Excessive Daytime Sleepiness

Jazz Pharmaceuticals plc and Aerial BioPharma, LLC announced that the companies have signed a definitive agreement under which Jazz Pharmaceuticals has acquired rights to ADX-N05, a novel compound in clinical development for the treatment of excessive daytime sleepiness in patients with narcolepsy. Under the agreement, a subsidiary of Jazz Pharmaceuticals has acquired worldwide development, manufacturing and commercial rights to ADX-N05, other than in certain countries in Asia where SK Biopharmaceuticals Co. Ltd. (SK) retains rights. Under the agreement, Aerial will receive an upfront payment of $125 million. Aerial and SK are eligible to receive milestone payments based on development, regulatory and sales milestones and tiered royalties based on potential future sales.

Similar Private Companies By Industry

Company Name Region
ProlX Pharmaceuticals Corporation United States
Reliv', Inc. United States
Virbac Corporation United States
Nexus Pharmaceuticals, Inc. United States
Matrix Denture Systems International, Inc United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aerial BioPharma LLC, please visit www.aerialbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.